A dicarboxylic acid monoester that is ethyl 4-phenylbutanoate in which a hydrogen alpha to the carboxy group is substituted by the amino group of L-alanyl-L-proline (S-configuration).
Synonyms: N-[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]-L-alanyl-L-proline Enalapril ENALAPRIL
Term information
- MetaCyc:CPD0-2065
- Patent:EP12401
- KEGG:D07892
- HMDB:HMDB0014722
- Beilstein:3657467
- PMID:23413003
- KEGG:C06977
- Wikipedia:Enalapril
- Drug_Central:1005
- DrugBank:DB00584
- LINCS:LSM-3282
- PMID:23030053
- CAS:75847-73-3
- Patent:US4374829
- PMID:10669559
3_STAR
Wikipedia:Enalapril
HMDB:HMDB0014722
PMID:23030053
MetaCyc:CPD0-2065
KEGG:C06977
Beilstein:3657467
Patent:EP12401
KEGG:D07892
LINCS:LSM-3282
CAS:75847-73-3
PMID:10669559
DrugBank:DB00584
PMID:23413003
Patent:US4374829
Drug_Central:1005
(S)-1-{(S)-2-[1-((S)-Ethoxycarbonyl)-3-phenyl-propylamino]-propionyl}-pyrrolidine-2-carboxylic acid
enalaprilum
enalaprila
enalapril
(S)-1-(N-(1-(ethoxycarbonyl)-3-phenylpropyl)-L-alanyl)-L-proline
analapril
1-(N-((S)-1-carboxy-3-phenylpropyl)-L-alanyl)-L-proline 1'-ethyl ester
InChI=1S/C20H28N2O5/c1-3-27-20(26)16(12-11-15-8-5-4-6-9-15)21-14(2)18(23)22-13-7-10-17(22)19(24)25/h4-6,8-9,14,16-17,21H,3,7,10-13H2,1-2H3,(H,24,25)/t14-,16-,17-/m0/s1